Gilder Gagnon Howe & CO LLC Incyte Corp Transaction History

Gilder Gagnon Howe & CO LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2018 Jul 31, 2018	SELL	$60.85 - $83.98 $96,629 - $133,360	-1,588 Closed	0 $0
Q1 2018 Apr 30, 2018	SELL	$83.06 - $100.98 $30.8 Million - $37.4 Million	-370,797 Reduced 99.57%	1,588 $132,000
Q4 2017 Jan 31, 2018	SELL	$93.56 - $116.6 $14.6 Million - $18.2 Million	-156,497 Reduced 29.59%	372,385 $35.3 Million
Q3 2017 Nov 06, 2017	BUY	$109.15 - $138.27 $57.7 Million - $73.1 Million	528,882	528,882 $61.7 Million

642

186M

714K

557K

Ticker INCY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 222,431,008
Market Cap $15.8B
Description
Incyte Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of proprietary therapeutics in the United States and internationally. The company offers JAKAFI, a drug for the treatment of myelofibrosis and polycythemia vera; PEMAZYRE, a fibroblast growth factor receptor kinase inhibitor that act as ...

Get notified when there are updates to the investment portfolio of Gilder Gagnon Howe & CO LLC, based on Form 13F filings with the SEC.

Stay updated on Gilder Gagnon Howe & CO LLC with notifications on news.